Subproteomics analysis of Ca2+-binding proteins demonstrates decreased calsequestrin expression in dystrophic mouse skeletal muscle

European Journal of Biochemistry

Volumn 271, Issue 19, 2004, Pages 3943-3952

  Doran, Philip ^a   Dowling, Paul ^a   Lohan, James ^a   McDonnell, Karen ^a   Poetsch, Stephan ^b   Ohlendieck, Kay ^a  

^a NATIONAL UNIVERSITY OF IRELAND   (Ireland)

^b GE Healthcare   (United States)

Author keywords

Calsequestrin; mdx; Mouse skeletal muscle; Muscular dystrophy; Sarcalumenin

Indexed keywords

CALCIUM BINDING PROTEIN; CALCIUM ION; CALSEQUESTRIN; DYSTROPHIN; MUSCLE PROTEIN; SARCALUMENIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL FRACTIONATION; CONTROLLED STUDY; DUCHENNE MUSCULAR DYSTROPHY; GENETIC DISORDER; IMMUNOBLOTTING; MASS SPECTROMETRY; MOUSE; MUSCLE NECROSIS; MUSCULAR DYSTROPHY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEOMICS; SARCOPLASMIC RETICULUM; SKELETAL MUSCLE;

ANIMALS; CALCIUM; CALMODULIN; CALSEQUESTRIN; DYSTROPHIN; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; IMMUNOBLOTTING; MASS SPECTROMETRY; MEMBRANE PROTEINS; MICE; MICE, INBRED C57BL; MICE, INBRED MDX; MUSCLE, SKELETAL; MUSCULAR DYSTROPHY, ANIMAL; PROTEOMICS; SUBCELLULAR FRACTIONS;

ANIMALIA;

EID: 4944230808     PISSN: 00142956     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1432-1033.2004.04332.x     Document Type: Article

References (53)

1. Emery, A.E. (2002) The muscular dystrophies. Lancet 359, 687-695.
2. Koenig. M., Hoffman, E.P., Bertelson, C.J., Monaco, A.P., Feener, C. & Kunkel, L.M. (1987) Complete cloning of the Duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals. Cell 50, 509-517.
3. Ervasti, J.M., Ohlendieck, K., Kahl, S.D., Gaver, M.G. & Campbell, K.P. (1990) Deficiency of a glycoprotein component of the dystrophin complex in dystrophic muscle. Nature 345, 315-319.
4. Kapsa, R., Kornberg, A.J. & Byrne, E. (2003) Novel therapies for Duchenne muscular dystrophy. Lancet Neurol. 2, 299-310.
5. Khurana, T.S. & Davies, K.E. (2003) Pharmacological strategies for muscular dystrophy. Nat. Rev. Drug Discov. 2, 379-390.
6. Badalamente, W.A. & Stracher, A. (2000) Delay of muscle degeneration and necrosis in mdx mice by calpain inhibition. Muscle Nerve 23, 106-111.
7. Tidball, J.G. & Spencer, M.J. (2000) Calpains and muscular dystrophy. Int. J. Biochem. Cell Biol. 32, 1-5.
8. Bogdanovich, S., Krag, T.O.B., Barton, E.R., Morris, L.D., Whittemore, L.A., Ahima, R.S. & Khurana, T.S. (2002) Functional improvement of dystrophic muscle by myostatin blockade. Nature 420, 418-421.
9. Partridge, T.A. (2002) Myoblast transplantation. Neuromuscul. Disord. 12, S3-S6.
10. Partridge, T.A. (2003) Stem cell route to neuromuscular therapies. Muscle Nerve 27, 133-141.
11. Bachrach, E., Li, S., Perez, A.L., Schienda, J., Liadaki, K., Volinski, J., Flint, A., Chamberlain, J. & Kunkel, L.M. (2004) Systemic delivery of human microdystrophin to regenerating mouse dystrophic muscle by muscle progenitor cells. Proc. Natl Acad. Sci. USA 101, 3581-3586.
12. Ahmad, A., Brinson, M., Hodges, B.L., Chamberlain, J.S. & Amalfitano, A. (2000) Mdx mice inducibly expressing dystrophin provide insights into the potential of gene therapy for Duchenne muscular dystrophy. Hum. Mol. Genet. 9, 2507-2515.
13. Wang, B., Li, J. & Xiao, X. (2000) Adeno-associated virus vector carrying human minidystrophin genes effectively ameliorates muscular dystrophy. Proc. Natl Acad. Sci. USA 97, 13714-13719.
14. Chamberlain, J.S. (2002) Gene therapy of muscular dystrophy. Hum. Mol. Genet. 11, 2355-2362.
15. Van Deutekom, J.C. & van Ommen, G.J. (2003) Advances in Duchenne muscular dystrophy gene therapy. Nat. Rev. Genet. 4, 774-783.
16. Tinsley, J.M. & Davies, K.E. (1993) Utrophin: a potential replacement for dystrophin? Neuromusc. Disord. 3, 537-539.
17. Emery, A.E. (2002) Muscular dystrophy into the new millennium. Neuromusc. Disord. 12, 343-349.
18. Tkatchenko, A.V., Le Cam, G., Leger, J.J. & Dechesne, C.A. (2000) Large-scale analysis of differential gene expression in the hindlimb muscles and diaphragm of mdx mouse. Biochim. Biophys. Acta 1500, 17-30.
19. Chen, Y.W., Zhao, P., Borup, R. & Hoffman, E.P. (2000) Expression profiling in the muscular dystrophies: identification of novel aspects of molecular pathophysiology. J. Cell Biol. 151, 1321-1336.
20. Alderton, J.M. & Steinhardt, R.A. (2000) Calcium influx through calcium leak channels is responsible for the elevated levels of calcium-dependent proteolysis in dystrophic myotubes. J. Biol. Chem. 275, 9452-9460.
21. Culligan, K. & Ohlendieck, K. (2002) Abnormal calcium handling in muscular dystrophy. Bash. Appl. Myol. 12, 147-157.
22. Alderton, J.M. & Steinhardt, R.A. (2000) How calcium influx through calcium leak channels is responsible for the elevated levels of calcium-dependent proteolysis in dystrophic myotubes. Trends Cardiovasc. Med. 10, 268-272.
23. Ohlendieck, K., Matsumura, K., Ionasescu, V.V., Towbin, J.A., Bosch, E.P., Weinstein, S.L., Sernett, S.W. & Campbell, K.P. (1993) Duchenne muscular dystrophy: deficiency of dystrophin-associated proteins in the sarcolemma. Neurology 43, 795-800.
24. Ohlendieck, K. & Campbell, K.P. (1991) Dystrophin-associated proteins are greatly reduced in skeletal muscle from mdx mice. J. Cell Biol. 115, 1685-1694.
25. Ohlendieck, K. (1996) Towards an understanding of the dystrophin-glycoprotein complex: linkage between the extracellular matrix and the subsarcolemmal membrane cytoskeleton. Eur. J. Cell Biol. 69, 1-10.
26. Clarke, M.S., Khakee, R. & McNeil, P.L. (1993) Loss of cytoplasmic basic fibroblast growth factor from physiologically wounded myofibers of normal and dystrophic muscle. J. Cell Sci. 106, 121-133.
27. + channels. Proc. Natl Acad. Sci. USA 97, 4950-4955.
28. Turner, P.R., Westwood, T., Regen, C.M. & Steinhardt, R.A. (1988) Increased protein degradation results from elevated free calcium levels found in muscle from mdx mice. Nature 335, 735-738.
29. Culligan, K., Banville, N., Dowling, P. & Ohlendieck, K. (2002) Drastic reduction of calsequestrin-like proteins and impaired calcium binding in dystrophic mdx muscle. J. Appl. Physiol. 92, 435-445.
30. Dowling, P., Doran, P. & Ohlendieck, K. (2004) Drastic reduction of sarcalumenin in Dp427-deficient fibres indicates that abnormal calcium handling plays a key role in muscular dystrophy. Biochem. J. 379, 479-488.
31. Dowling, P., Lohan, J. & Ohlendieck, K. (2003) Comparative analysis of Dp427-deficient mdx tissues shows that the milder dystrophic phenotype of extraocular and toe muscle fibres is associated with a persistent expression of beta-dystroglycan. Eur. J. Cell Biol. 82, 222-230.
32. 2+-binding proteins, calsequestrin, calmodulin, troponin C, and S-100, with the cationic carbocyanine dye 'Stains-all'. J. Biol. Chem. 258, 11267-11273.
33. 1dihydropyridine receptor in rabbit skeletal muscle triads. Biochem. J. 324, 689-696.
34. Isfort, R.J. (2002) Proteomic analysis of striated muscle. J. Chromatogr. B 771, 155-165.
35. Sanchez, J.C., Chiappe, D., Converset, V., Hoogland, C., Binz, P.A., Paesano, S., Appel, R.D., Wang, S., Sennitt, M., Nolan, A., Cawthorne, M.A. & Hochstrasser, D.F. (2001) The mouse SWISS-2DPAGE database: a tool for proteomics study of diabetes and obesity. Proteomics 1, 136-163.
36. Westermeier, R. & Naven, T. (2002) Practical Proteomics. Wiley-VCH-Verlag, Weinheim, Germany.
37. Froemming, G.R. & Ohlendieck, K. (2001) The native dihydropyridine receptor exists as a supramolecular complex in skeletal muscle. Cell. Mol. Life Sci. 58, 312-320.
38. Towbin, H., Staehelin, T. & Gordon, J. (1979) Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl Acad. Sci. USA 76, 4350-4354.
39. Bradd, S.J. & Dunn, M.J. (1993) Analysis of membrane proteins by Western blotting and enhanced chemiluminescence. Methods Mol. Biol. 19, 211-218.
40. Maeda, T., Chapman, D.L. & Stewart, A.F. (2002) Mammalian vestigial-like 2, a cofactor of TEF-1 and MEF2 transcription factors that promotes skeletal muscle differentiation. J. Biol. Chem. 277, 49999-49999.
41. Watchko, J.F., O'Day, T.L. & Hoffman, E.P. (2002) Functional characteristics of dystrophic skeletal muscle: insights from animal models. J. Appl. Physiol. 93, 407-417.
42. Durbeej, M. & Campbell, K.P. (2002) Muscular dystrophies involving the dystrophin-glycoprotein complex: an overview of current mouse models. Curr. Opin. Genet. Dev. 12, 349-361.
43. Sicinski, P., Geng, Y., Ryder-Cook, A.S., Barnard, E.A., Darlison, M.G. & Barnard, P.J. (1989) The molecular basis of muscular dystrophy in the mdx mouse: a point mutation. Science 244, 1578-1580.
44. Ohlendieck, K., Ervasti, J.M., Snook, J.B. & Campbell, K.P. (1991) Dystrophin-glycoprotein complex is highly enriched in isolated skeletal muscle sarcolemma. J. Cell Biol. 112, 135-148.
45. Niebroj-Dobosz, I., Kornguth, S., Schutta, H., Siegel, F.L. & Hausmanowa-Petrusewicz, I. (1989) Proteins of muscle subcellular fractions in Duchenne progressive muscular dystrophy stained with 'stains-all' cationic carbocyanine dye and with Coomassie Blue: Muscle Nerve 12, 273-280.
46. MacLennan, D.H. & Reithmeier, R.A. (1998) Ion tamers. Nat. Struct. Biol. 5, 409-411.
47. Glover, L., Quinn, S., Ryan, M., Pette, D. & Ohlendieck, K. (2002) Supramolecular calsequestrin complex. Eur. J. Biochem. 269, 4607-4616.
48. Franzini-Armstrong, C., Kenney, L.J. & Varriano-Marston, E. (1987) The structure of calsequestrin in triads of vertebrate skeletal muscle: a deep-etch study. J. Cell Biol. 105, 49-56.
49. 2+-cycling proteins. J. Mol. Cell. Cardiol. 34, 897-918.
50. Leong, P. & MacLennan, D.H. (1998) Complex interactions between skeletal muscle ryanodine receptor and dihydropyridine receptor proteins. Biochem. Cell Biol. 76, 681-694.
51. Ohkura, M., Furukawa, K., Fujimori, H., Kuruma, A., Kawano, S., Hiraoka, M., Kuniyasu, A., Nakayama, H. & Ohizumi, Y. (1998) Dual regulation of the skeletal muscle ryanodine receptor by triadin and calsequestrin. Biochemistry 37, 12987-12993.
52. 2+-regulatory membrane proteins in normal, stimulated and pathological skeletal muscle fibres (review). Int. J. Mol. Med. 1, 677-697.
53. Duncan, C.J. (1978) Role of intracellular calcium in promoting muscle damage: a strategy for controlling the dystrophic condition. Experientia 34, 1531-1535.